Influx Health.

Not Rated
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0MYZ01012
  • NSEID: INFLUX
  • BSEID:
INR
202.05
-9.3 (-4.4%)
BSENSE

Jan 19

BSE+NSE Vol: 12600

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2025 is 4.89% vs 31.44% in Mar 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2025 is 21.32% vs 58.01% in Mar 2024

stock-summary

Interest

YoY Growth in year ended Mar 2025 is -97.77% vs 273.96% in Mar 2024

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2025 is 20.11% vs 54.64% in Mar 2024

Compare Profit and Loss Results of Influx Health.
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
104.00
0
104.00
0%
Less :Inter divisional transfers
0.00
0
0.00
0%
Less: Excise
0.00
0
0.00
0%
Net Sales
104.00
0
104.00
0%
Expenditure (Ex Depriciation)
Stock Adjustments
0.00
0
0.00
0%
Raw Materials Consumed
63.00
0
63.00
0%
Power & Fuel Cost
1.00
0
1.00
0%
Employee Cost
8.00
0
8.00
0%
Operating Expenses
7.00
0
7.00
0%
General and Administration Expenses
-1.00
0
-1.00
0%
Selling and Distribution Expenses
1.00
0
1.00
0%
Cost of Software developments
0.00
0
0.00
0%
Miscellaneous Expenses
0.00
0
0.00
0%
Expenses Capitalised
0.00
0
0.00
0%
Total Expenditure
84.00
0
84.00
0%
Operating Profit (PBDIT) excl Other Income
20.00
0.00
20.00
0%
Other Income
0.00
0
0.00
0%
Operating Profit (PBDIT)
20.00
0
20.00
0%
Interest
0.00
0
0.00
0%
Profit before Depriciation and Tax
20.00
0
20.00
0%
Depreciation
2.00
0
2.00
0%
Profit Before Taxation & Exceptional Items
17.00
0
17.00
0%
Exceptional Income / Expenses
0.00
0
0.00
0%
Profit Before Tax
17.00
0
17.00
0%
Provision for Tax
4.00
0
4.00
0%
Profit After Tax
13.00
0
13.00
0%
Extraordinary Items
0.00
0
0.00
0%
Adj to Profit After Tax
0.00
0
0.00
0%
Profit Balance B/F
16.00
0
16.00
0%
Profit Available for appropriations
29.00
0
29.00
0%
Appropriations
29.00
0
29.00
0%
Equity Dividend (%)
0%
0%
0.00
Earnings Per Share
7.36
0
7.36
0%
Profit And Loss - Net Sales
Net Sales 104.85 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 4.89% vs 31.44% in Mar 2024

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.58 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 21.32% vs 58.01% in Mar 2024

Profit And Loss - Interest
Interest 0.01 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is -97.77% vs 273.96% in Mar 2024

Profit And Loss - Profit After Tax
Profit After Tax 13.37 Cr
in Mar 2025

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2025 is 20.11% vs 54.64% in Mar 2024